2024-03-29T15:04:11Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_FFB7B759EC40
2024-03-23T03:16:22Z
serval:BIB_FFB7B759EC40
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.
10.1172/JCI97040
31961340
Cheng
J.
author
Klei
L.R.
author
Hubel
N.E.
author
Zhang
M.
author
Schairer
R.
author
Maurer
L.M.
author
Klei
H.B.
author
Kang
H.
author
Concel
V.J.
author
Delekta
P.C.
author
Dang
E.V.
author
Mintz
M.A.
author
Baens
M.
author
Cyster
J.G.
author
Parameswaran
N.
author
Thome
M.
author
Lucas
P.C.
author
McAllister-Lucas
L.M.
author
article
2020-02-03
The Journal of clinical investigation
1558-8238
0021-9738
journal
130
2
1036-1051
Immunology
Lymphomas
NF-kappaB
Oncology
Signal transduction
eng
60_published
true
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_FFB7B759EC40
https://serval.unil.ch/resource/serval:BIB_FFB7B759EC40.P001/REF.pdf
Restricted: indefinite embargo
Copying allowed only for non-profit organizations